Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group.

Elena FountzilasGeorgia-Angeliki KoliouAthanassios VozikisVassiliki RaptiAchilleas NikolakopoulosAnastasios BoutisAthina ChristopoulouIoannis KontogiorgosSofia KarageorgopoulouEfthalia LallaDimitrios TryfonopoulosIoannis BoukovinasCleopatra RaptiAdamantia NikolaidiSofia KarteriEvangelia MoirogiorgouIoannis BinasDavide MauriGerasimos AravantinosFlora ZagouriZacharenia SaridakiAmanda PsyrriDimitrios BafaloukosAnna KoumarianouEleni ResHelena LinardouGiannis MountziosEvangelia RazisGeorge FountzilasGeorgios Koumakis

Published in: ESMO open (2021)

NCT04133207.

Keyphrases

cell cycle
palliative care
electronic health record
oxidative stress
big data
protein kinase
stem cells
cell cycle arrest
cell therapy
mesenchymal stem cells